GHK Wellness Package customers undergoing the brand new "Histotripsy treatment - Liver cancer treatment package" at GHK will be also eligible for full reimbursement¹ of the package expenses and an additional HKD 500 cash benefit² until further notice*.

Histotripsy technology has been approved by the U.S. FDA but is currently still in the clinical trial stage in Hong Kong. As such, this technology is not yet covered under VHIS at this stage. However, Bowtie is committed to supporting emerging medical technologies and promoting transparent pricing through packaged treatment plans. As a trial initiative, we are offering ex gratia coverage for Histotripsy-related treatment packages under the GHK Wellness Package.

If needed, you can contact GHK to arrange a doctor consultation and a “Histotripsy Comprehensive Evaluation Package” to determine whether this treatment is suitable for you.

After the evaluation, if you are confirmed to be eligible and proceed with the "Histotripsy Treatment – Liver Cancer Treatment Package," the cost of the "Histotripsy Comprehensive Evaluation Package" will also be fully reimbursed.

What is Histotripsy?
Histotripsy is an innovative, non-invasive treatment that uses focused ultrasound to precisely target and destroy liver tumors. This technique requires no incisions, radiation, or needles, typically causes minimal pain, and has fewer side effects and complications. It offers a promising alternative to traditional treatments, especially for patients who are not eligible for surgery.
For more details, please contact GHK at 3153 9611.

¹ The deductible of Bowtie Pink is not covered. The Insured Person has to pay out of pocket to GHK directly for all the fees that have not been pre-approved by Bowtie before discharge.
² Cash Benefit applies to the use of Designated Medical Packages and is not subject to the annual or lifetime benefit limit (if applicable) of the Bowtie VHIS Flexi or Bowtie Pink VHIS.
*The reimbursement for the "Histotripsy Treatment - Liver Cancer Treatment Package"  is an ex-gratia arrangement and it is subject to the annual or lifetime benefit limit (if applicable) of the relevant VHIS plan. If any additional expenses arise during this treatment, including complications, further surgeries, or intensive care, these costs will be reimbursed according to the relevant VHIS benefit schedule. This arrangement will take effect from March 14, 2025, until further notice.